| pubmed-article:9217891 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9217891 | lifeskim:mentions | umls-concept:C0012655 | lld:lifeskim |
| pubmed-article:9217891 | lifeskim:mentions | umls-concept:C0878544 | lld:lifeskim |
| pubmed-article:9217891 | lifeskim:mentions | umls-concept:C0080194 | lld:lifeskim |
| pubmed-article:9217891 | lifeskim:mentions | umls-concept:C0020557 | lld:lifeskim |
| pubmed-article:9217891 | lifeskim:mentions | umls-concept:C0011847 | lld:lifeskim |
| pubmed-article:9217891 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:9217891 | lifeskim:mentions | umls-concept:C1705241 | lld:lifeskim |
| pubmed-article:9217891 | lifeskim:mentions | umls-concept:C1705242 | lld:lifeskim |
| pubmed-article:9217891 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:9217891 | pubmed:dateCreated | 1997-8-11 | lld:pubmed |
| pubmed-article:9217891 | pubmed:abstractText | Streptozotocin (STZ)-induced diabetes in Wistar rats results in severe hyperlipidemia and a characteristic cardiomyopathy. However, Wistar-Kyoto (WKY) rats made diabetic with a similar dose of STZ did not develop heart dysfunction or hypertriglyceridemia at 12 weeks post-STZ. We investigated whether an apparent resistance of the WKY strain to develop diabetic cardiomyopathy and hypertriglyceridemia following chronic diabetes could be due to a reduced susceptibility to the diabetogenic effects of STZ. | lld:pubmed |
| pubmed-article:9217891 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9217891 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9217891 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9217891 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9217891 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9217891 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9217891 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:9217891 | pubmed:issn | 0008-6363 | lld:pubmed |
| pubmed-article:9217891 | pubmed:author | pubmed-author:GoyalR KRK | lld:pubmed |
| pubmed-article:9217891 | pubmed:author | pubmed-author:McNeillJ HJH | lld:pubmed |
| pubmed-article:9217891 | pubmed:author | pubmed-author:CaiM GMG | lld:pubmed |
| pubmed-article:9217891 | pubmed:author | pubmed-author:KoneLL | lld:pubmed |
| pubmed-article:9217891 | pubmed:author | pubmed-author:RodriguesBB | lld:pubmed |
| pubmed-article:9217891 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9217891 | pubmed:volume | 34 | lld:pubmed |
| pubmed-article:9217891 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9217891 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9217891 | pubmed:pagination | 199-205 | lld:pubmed |
| pubmed-article:9217891 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9217891 | pubmed:meshHeading | pubmed-meshheading:9217891-... | lld:pubmed |
| pubmed-article:9217891 | pubmed:meshHeading | pubmed-meshheading:9217891-... | lld:pubmed |
| pubmed-article:9217891 | pubmed:meshHeading | pubmed-meshheading:9217891-... | lld:pubmed |
| pubmed-article:9217891 | pubmed:meshHeading | pubmed-meshheading:9217891-... | lld:pubmed |
| pubmed-article:9217891 | pubmed:meshHeading | pubmed-meshheading:9217891-... | lld:pubmed |
| pubmed-article:9217891 | pubmed:meshHeading | pubmed-meshheading:9217891-... | lld:pubmed |
| pubmed-article:9217891 | pubmed:meshHeading | pubmed-meshheading:9217891-... | lld:pubmed |
| pubmed-article:9217891 | pubmed:meshHeading | pubmed-meshheading:9217891-... | lld:pubmed |
| pubmed-article:9217891 | pubmed:meshHeading | pubmed-meshheading:9217891-... | lld:pubmed |
| pubmed-article:9217891 | pubmed:meshHeading | pubmed-meshheading:9217891-... | lld:pubmed |
| pubmed-article:9217891 | pubmed:meshHeading | pubmed-meshheading:9217891-... | lld:pubmed |
| pubmed-article:9217891 | pubmed:meshHeading | pubmed-meshheading:9217891-... | lld:pubmed |
| pubmed-article:9217891 | pubmed:meshHeading | pubmed-meshheading:9217891-... | lld:pubmed |
| pubmed-article:9217891 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9217891 | pubmed:articleTitle | Strain differences in susceptibility to streptozotocin-induced diabetes: effects on hypertriglyceridemia and cardiomyopathy. | lld:pubmed |
| pubmed-article:9217891 | pubmed:affiliation | Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancourer, Canada. | lld:pubmed |
| pubmed-article:9217891 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9217891 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:9217891 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9217891 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9217891 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9217891 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9217891 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9217891 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9217891 | lld:pubmed |
